Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response.

MLA

Suprewicz, Łukasz, et al. “Ceragenins Exhibit Antiviral Activity against SARS-CoV-2 by Increasing the Expression and Release of Type I Interferons upon Activation of the Host’s Immune Response.” Antiviral Research, vol. 217, Sept. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.antiviral.2023.105676.

APA

Suprewicz, Ł., Szczepański, A., Lenart, M., Piktel, E., Fiedoruk, K., Barreto-Duran, E., Kula-Pacurar, A., Savage, P. B., Milewska, A., Bucki, R., & Pyrć, K. (2023). Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host’s immune response. Antiviral Research, 217, N.PAG. https://doi.org/10.1016/j.antiviral.2023.105676

Chicago

Suprewicz, Łukasz, Artur Szczepański, Marzena Lenart, Ewelina Piktel, Krzysztof Fiedoruk, Emilia Barreto-Duran, Anna Kula-Pacurar, et al. 2023. “Ceragenins Exhibit Antiviral Activity against SARS-CoV-2 by Increasing the Expression and Release of Type I Interferons upon Activation of the Host’s Immune Response.” Antiviral Research 217 (September): N.PAG. doi:10.1016/j.antiviral.2023.105676.